Article
Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: a retrospective analysis of 49 cases.
Clinical rheumatology - 1 Jun 2012
Ryu Han Hee, Lee Eun Young, Shin Kichul, Choi In Ah, Lee Yun Jong, Yoo Bin, Park Min-Chan, Park Yong-Beom, Bae Sang-Cheol, Yoo Wan Hee, Kim Sung Il, Lee Eun Bong, Song Yeong Wook
Abstract excerpt
Clinical guidelines regarding anti-viral prophylaxis for HBV surface antigen (HBsAg) carriers starting anti-TNFα agents are not yet fully established, even in endemic regions of HBV infection. We retrospectively collected the clinical data of 52 HBsAg carriers with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) that had been administered anti-TNFα treatment at seven medical centers in South Korea....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
